Authors

• Eleftheria Tsakalozou (ORCID: https://orcid.org/0000-0003-1993-8528)
• Jessica Spires (ORCID: https://orcid.org/0000-0002-1686-655X)
• James F. Clarke (ORCID: https://orcid.org/0000-0002-9417-4567)
• Flora T. Musuamba (ORCID: https://orcid.org/0000-0001-8276-8870)
• Markus Fridén (ORCID: https://orcid.org/0000-0001-5029-2417)
• Abdullah Hamadeh (ORCID: https://orcid.org/0000-0002-9419-1797)
• Ming‐Liang Tan (ORCID: https://orcid.org/0000-0003-1457-2168)
• Ross Walenga (ORCID: https://orcid.org/0000-0003-3261-4245)
• Khondoker Alam (ORCID: https://orcid.org/0000-0001-8757-2412)
• Jan De Backer
• Sujatha Sonti
• Jay Mowli

Institutions

• United States Food and Drug Administration (US)
• Center for Drug Evaluation and Research (US)
• University of Namur (BE)
• University of Waterloo (CA)
• Fluidda (United States) (US)
• GlaxoSmithKline (United States) (US)
• AstraZeneca (Sweden) (SE)
• Simulations Plus (United States) (US)

Publication Details

Journal

Pharmaceutical Research

Published

2025-02-26

DOI

https://doi.org/10.1007/s11095-025-03823-5

Citations

1

Primary Topic

Safe Handling of Antineoplastic Drugs

Type

article

Field-Weighted Citation Impact

5.77